Ken Fisher Charles River Laboratories International, Inc. Transaction History

Fisher Asset Management, LLC

$247 Billion
Q4 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 232,318 shares of CRL stock, worth $38.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

232,318

Previous 184,692 25.79%

Holding current value

$38.8 Million

Previous $36.4 Million 17.87%

% of portfolio

0.02%

Previous 0.01%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$178.58 - $220.69 $8.51 Million - $10.5 Million	47,626 Added 25.79%	232,318 $42.9 Million
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $298,104 - $389,029	1,586 Added 0.87%	184,692 $36.4 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $319,698 - $416,262	-1,549 Reduced 0.84%	183,106 $37.8 Million
Q1 2024 May 09, 2024	SELL	$203.52 - $273.43 $360,433 - $484,244	-1,771 Reduced 0.95%	184,655 $50 Million
Q4 2023 Mar 05, 2024	SELL	$164.52 - $238.84 $329 - $477	-2 Reduced -0.0%	186,426 $44.1 Million
Q4 2023 Feb 06, 2024	SELL	$164.52 - $238.84 $373,789 - $542,644	-2,272 Reduced 1.2%	186,428 $44.1 Million
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $2.66 Million - $2.97 Million	-13,667 Reduced 6.75%	188,700 $37 Million
Q2 2023 Dec 12, 2023	BUY	$183.71 - $210.25 $2.51 Million - $2.87 Million	13,667 Added 7.24%	202,367 $42.5 Million
Q2 2023 Aug 08, 2023	SELL	$183.71 - $210.25 $7.3 Million - $8.35 Million	-39,723 Reduced 16.41%	202,367 $42.5 Million
Q1 2023 Dec 12, 2023	BUY	$191.89 - $259.92 $5.28 Million - $7.16 Million	27,535 Added 14.59%	216,235 $43.6 Million
Q1 2023 May 01, 2023	SELL	$191.89 - $259.92 $1.74 Million - $2.35 Million	-9,050 Reduced 3.6%	242,090 $48.9 Million
Q4 2022 Feb 03, 2023	BUY	$197.11 - $250.07 $2.05 Million - $2.6 Million	10,381 Added 4.31%	251,140 $54.7 Million
Q3 2022 Nov 08, 2022	SELL	$182.44 - $250.54 $2.24 Million - $3.07 Million	-12,266 Reduced 4.85%	240,759 $47.4 Million
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $945,326 - $1.4 Million	4,631 Added 1.86%	253,025 $54.1 Million
Q1 2022 May 05, 2022	SELL	$255.51 - $362.11 $835,006 - $1.18 Million	-3,268 Reduced 1.3%	248,394 $70.5 Million
Q4 2021 Feb 02, 2022	BUY	$351.38 - $448.68 $2.99 Million - $3.82 Million	8,521 Added 3.5%	251,662 $94.8 Million
Q3 2021 Oct 26, 2021	BUY	$372.64 - $458.3 $2.95 Million - $3.62 Million	7,909 Added 3.36%	243,141 $100 Million
Q2 2021 Jul 27, 2021	SELL	$294.17 - $371.65 $851,916 - $1.08 Million	-2,896 Reduced 1.22%	235,232 $87 Million
Q1 2021 Apr 27, 2021	SELL	$249.67 - $299.48 $851,624 - $1.02 Million	-3,411 Reduced 1.41%	238,128 $69 Million
Q4 2020 Jan 29, 2021	SELL	$222.0 - $252.62 $1.91 Million - $2.17 Million	-8,586 Reduced 3.43%	241,539 $60.4 Million
Q3 2020 Nov 10, 2020	SELL	$175.56 - $226.45 $3.77 Million - $4.86 Million	-21,479 Reduced 7.91%	250,125 $56.6 Million
Q2 2020 Aug 07, 2020	SELL	$118.84 - $189.72 $2.63 Million - $4.19 Million	-22,107 Reduced 7.53%	271,604 $47.4 Million
Q1 2020 Apr 28, 2020	SELL	$98.9 - $178.34 $5.33 Million - $9.6 Million	-53,851 Reduced 15.49%	293,711 $37.1 Million
Q4 2019 Feb 12, 2020	SELL	$126.05 - $152.76 $11.4 Million - $13.9 Million	-90,809 Reduced 20.72%	347,562 $53.1 Million
Q3 2019 Oct 29, 2019	SELL	$125.07 - $143.67 $4.12 Million - $4.74 Million	-32,970 Reduced 6.99%	438,371 $58 Million
Q2 2019 Jul 30, 2019	BUY	$123.4 - $148.55 $3.7 Million - $4.45 Million	29,980 Added 6.79%	471,341 $66.9 Million
Q1 2019 Apr 22, 2019	BUY	$104.82 - $146.73 $596,425 - $834,893	5,690 Added 1.31%	441,361 $64.1 Million
Q4 2018 Jan 25, 2019	BUY	$105.09 - $137.23 $5.93 Million - $7.74 Million	56,394 Added 14.87%	435,671 $49.3 Million
Q3 2018 Oct 24, 2018	BUY	$112.11 - $134.54 $1.63 Million - $1.96 Million	14,538 Added 3.99%	379,277 $51 Million
Q2 2018 Jul 09, 2018	SELL	$102.37 - $117.25 $1.42 Million - $1.63 Million	-13,881 Reduced 3.67%	364,739 $40.9 Million
Q1 2018 May 11, 2018	SELL	$98.19 - $115.2 $22.2 Million - $26 Million	-225,610 Reduced 37.34%	378,620 $40.4 Million
Q1 2018 Apr 19, 2018	BUY	$98.19 - $115.2 $16.5 Million - $19.4 Million	168,202 Added 38.58%	604,230 $64.5 Million
Q4 2017 Jan 24, 2018	SELL	$100.43 - $118.09 $1.62 Million - $1.9 Million	-16,128 Reduced 3.57%	436,028 $47.7 Million
Q3 2017 Oct 17, 2017	BUY	$96.72 - $109.26 $43.7 Million - $49.4 Million	452,156	452,156 $48.8 Million

Others Institutions Holding CRL

# of Institutions

709

Shares Held

49.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account